Table 1.
UIA patients with AWE (n = 12) | UIA patients with non-AWE (n = 6) | Healthy control (n = 5) | P Value | |
---|---|---|---|---|
Age (yr) | 53.0 ± 13.9 | 45.2 ± 10.3 | 24.8 ± 2.5 | 0.001 |
Female | 8 (66.7%) | 2 (33.3%) | 0 | 0.035 |
Hypertension | 7 (58.3%) | 2 (33.3%) | 0 | 0.076 |
Smoking | 2 (16.7%) | 2 (33.3%) | 0 | 0.379 |
Size | 6.15 (3.8-16.2) |
4.15 (3.2-6.5) |
N/A | 0.025 |
Location | 0.083 | |||
Anterior circulation | 11 (91.7%) | 14 (77.8%) | N/A | |
Posterior circulation | 1 (8.3%) | 3 (50%) | N/A | |
Irregular shape | 7 (58.3%) | 2 (33.3%) | N/A | 0.620 |
CRstalk | 0.48 (0.32-0.75) |
0.23 (0.07-0.26) |
N/A | 0.001 |
hsa_circ_0007990 | 4.19 ± 1.48 | 1.78 ± 0.51 | 1.00 ± 0.19 | < 0.001 |
AWE, aneurysm wall enhancement; CRstalk, aneurysm-to-pituitary stalk contrast ratio; UIA, unruptured intracranial aneurysm.
N/A, Not available.